(9α,13α)-5,6,8,14-Tetradehydro-2,3,4,6-tetramethoxy-17-(trifluoroacetyl)-B-homomorphinan-7-one (56793-04-5)
Identification |
Properties |
Safety Data |
|
|
Other Product
- B-Homomorphinan-7-one,5,6,8,14-tetradehydro-3-hydroxy-2,4,6-trimethoxy-17-methyl- (9CI)
- (9α,13α)-5,6,8,14-Tetradehydro-2-hydroxy-3,6-dimethoxymorphinan-7-one
- (9α,13α)-17-(Cyclopropylmethyl)-4,5β-epoxy-3,14α-dihydroxymorphinan-6-one
- (9α,13α,14α)-5,6-Didehydro-4-hydroxy-3,6-dimethoxy-17-methylmorphinan-7-one
- (9α,13α)-5,6-Didehydro-2-hydroxy-3,6-dimethoxy-17-methylmorphinan-7-one
- 9α,13α-Epidioxyabiet-8(14)-en-18-oic acid
- Benzo[3,4]-18-norandrosta-3,12,15-trien-17- one,6'-ethyl-1',2',3',4',5',6'-hexahydro-7- hydroxy-4,6',8-trimethyl-,(3â,4R,6'R,7â,8R,9â,- 10R,14â)-
- 1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
- 1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
- 1/C11H9N5O/c1-17-6-2-3-8-9(4-6)16-11(14-8)7(5-12)10(13)15-16/h2-4,14H,1H3,(H2,13,15
- 1/C12H11NO4/c1-6-10(15)7-3-4-13-8(5-14)9(7)11(16)12(6)17-2/h3-4,14H,5H2,1-2H
- Morphinan,3-methoxy-17-methyl-, (9α,13α,14α)-
- (9α,13α,14α)-5,6-Didehydro-3-methoxy-17-methylmorphinan
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
- 1/C15H18N2O/c18-15-12-7-3-2-6-11(12)14-16-13-8-4-1-5-10(13)9-17(14)15/h2-3,6-7,10,13-14,16H,1,4-5,8-9H2/t10-,13-,14-/m1/s
- 1/C15H22O3/c1-9-10(2)14-12(11(3)13(9)17)5-6-15(4,18-14)7-8-16/h16-17H,5-8H2,1-4H
- 1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H